- Waltham, MA
- November 29, 2018
An experienced C-level executive in both public and private biotech companies responsible for the overall design and execution of the corporate strategic plan. As such he is responsible for strategic preclinical and clinical development, clinical trials operations, management of contracts and outsourcing, and intellectual property.
A drug development professional with extensive experience in process development, manufacturing, quality assurance and regulatory and clinical affairs in both biologics and small molecule pharmaceuticals in a wide range of therapeutic areas.
As a member of senior management, has been involved in strategic corporate development, joint venture collaborations, in- and out-licensing deals, portfolio management and corporate communications and branding.